Status:
COMPLETED
Pilot Study Freeze and Transport Immune Cells
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Diphtheria
Hepatitis B
Eligibility:
FEMALE
18+ years
Brief Summary
To evaluate and standardize umbilical cord specimen collection and laboratory procedures to evaluate cellular and serological immune responses in neonates and young infants
Detailed Description
To evaluate: 1) The procedures for obtaining umbilical cord blood; 2) the methods for ensuring immune cell viability, freezing, and shipping; 3) the conditions for optimization of immune cell isolatio...
Eligibility Criteria
Inclusion
- For the portion of the pilot study conducted at the UCLA CVR, an umbilical cord blood sample will be obtained from approximately 8 to 12 healthy pregnant women who are delivering neonates at the Obstetrical delivery ward of Harbor- UCLA Medical Center. Informed consent will not be obtained because the blood will be obtained after delivery from a clamped umbilical cord attached to the placenta (afterbirth) that otherwise would be discarded.
Exclusion
- A cord blood sample will not be collected from women who have requested special arrangements for a cord blood registry service.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
February 1 2005
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00138268
End Date
February 1 2005
Last Update
August 27 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Center For Vaccine Research
Torrance, California, United States, 90502